Yagita H - Search Results

1

Interleukin 21 enhances antibody-mediated tumor rejection.

Smyth MJ, Teng MW, Sharkey J, Westwood JA, Haynes NM, Yagita H, Takeda K, Sivakumar PV, Kershaw MH. Smyth MJ, et al. Among authors: yagita h. Cancer Res. 2008 Apr 15;68(8):3019-25. doi: 10.1158/0008-5472.CAN-07-6019. Cancer Res. 2008. PMID: 18413772

2

Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.

Smyth MJ, Ortaldo JR, Shinkai Y, Yagita H, Nakata M, Okumura K, Young HA. Smyth MJ, et al. Among authors: yagita h. J Exp Med. 1990 Apr 1;171(4):1269-81. doi: 10.1084/jem.171.4.1269. J Exp Med. 1990. PMID: 1691263 Free PMC article.

3

Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo.

Nakata M, Smyth MJ, Norihisa Y, Kawasaki A, Shinkai Y, Okumura K, Yagita H. Nakata M, et al. Among authors: yagita h. J Exp Med. 1990 Dec 1;172(6):1877-80. doi: 10.1084/jem.172.6.1877. J Exp Med. 1990. PMID: 2124255 Free PMC article.

4

IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.

Smyth MJ, Ortaldo JR, Bere W, Yagita H, Okumura K, Young HA. Smyth MJ, et al. Among authors: yagita h. J Immunol. 1990 Aug 15;145(4):1159-66. J Immunol. 1990. PMID: 2143209

5

Contribution of Fas ligand to T cell-mediated hepatic injury in mice.

Seino K, Kayagaki N, Takeda K, Fukao K, Okumura K, Yagita H. Seino K, et al. Among authors: yagita h. Gastroenterology. 1997 Oct;113(4):1315-22. doi: 10.1053/gast.1997.v113.pm9322527. Gastroenterology. 1997. PMID: 9322527

6

Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.

Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M. Mogi S, et al. Among authors: yagita h. Clin Cancer Res. 1998 Mar;4(3):713-20. Clin Cancer Res. 1998. PMID: 9533541

7

Critical role of NK1+ T cells in IL-12-induced immune responses in vivo.

Kawamura T, Takeda K, Mendiratta SK, Kawamura H, Van Kaer L, Yagita H, Abo T, Okumura K. Kawamura T, et al. Among authors: yagita h. J Immunol. 1998 Jan 1;160(1):16-9. J Immunol. 1998. PMID: 9551949

8

Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.

Nakajima A, Kodama T, Morimoto S, Azuma M, Takeda K, Oshima H, Yoshino S, Yagita H, Okumura K. Nakajima A, et al. Among authors: yagita h. J Immunol. 1998 Aug 15;161(4):1901-7. J Immunol. 1998. PMID: 9712059

9

Expression of CD30 ligand (CD153) on murine activated T cells.

Shimozato O, Takeda K, Yagita H, Okumura K. Shimozato O, et al. Among authors: yagita h. Biochem Biophys Res Commun. 1999 Mar 24;256(3):519-26. doi: 10.1006/bbrc.1999.0336. Biochem Biophys Res Commun. 1999. PMID: 10080930

10

Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12.

Kodama T, Takeda K, Shimozato O, Hayakawa Y, Atsuta M, Kobayashi K, Ito M, Yagita H, Okumura K. Kodama T, et al. Among authors: yagita h. Eur J Immunol. 1999 Apr;29(4):1390-6. doi: 10.1002/(SICI)1521-4141(199904)29:04<1390::AID-IMMU1390>3.0.CO;2-C. Eur J Immunol. 1999. PMID: 10229107 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,034 results

Search Page

Filters